Erratum: Neurotherapeutic effects of novel HO-1 inhibitors in vitro and in a transgenic mouse model of Alzheimer's disease (Journal of Neurochemistry (2014) DOI: 10.1111/jnc.12927);Neurotherapeutic effects of novel HO-1 inhibitors in vitro and in a transgenic mouse model of Alzheimer's disease

Journal of Neurochemistry

Volumn 131, Issue 6, 2014, Pages 778-790

  Gupta, Ajay ^a,b   Lacoste, Baptiste ^c   Pistel, Paul J ^d   Ingram, Donald K ^e   Hamel, Edith ^c   Alaoui Jamali, Moulay A ^b,f   Szarek, Walter A ^g   Vlahakis, Jason Z ^g   Jie, Su ^b,f   Song, Wei ^b,f   Schipper, Hyman M ^b,f  

^a Osta Biotechnologies Inc   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d TOWSON UNIVERSITY   (United States)

^e Lousiana State University   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g QUEEN S UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; bioenergetic failure; heme oxygenase 1; oxidative stress

Indexed keywords

HEME OXYGENASE 1; HEME OXYGENASE INHIBITOR; MEMANTINE; OB 28; PLACEBO; QC 47; QC 56; UNCLASSIFIED DRUG; OB28 COMPOUND; PYRROLE DERIVATIVE;

ADULT; ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DRUG EFFECT; GENE; HMOX1 GENE; IN VITRO STUDY; INTRACELLULAR SPACE; MALE; MITOCHONDRION; MOUSE; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; AGING; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; DRUG EFFECTS; GENETICS; GLIA; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS; RATTUS;

AGING; ALZHEIMER DISEASE; ANIMALS; ASTROCYTES; AZOLES; DISEASE MODELS, ANIMAL; HEME OXYGENASE-1; HUMANS; MALE; MICE; MICE, TRANSGENIC; MITOCHONDRIA; NEUROGLIA; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 84918496737     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12952     Document Type: Erratum

References (61)

1. Akiyama H., Barger S., and, Barnum S., et al,. (2000) Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383-421.
2. Alaoui-Jamali M. A., Bismar T. A., Gupta A., et al,. (2009) A novel experimental heme oxygenase-1 targeted therapy for hormone-refractory prostate cancer. Cancer Res. 69, 8017-8024.
3. Baranano D. E., and, Snyder S. H., (2001) Neural roles for heme oxygenase: contrasts to nitric oxide synthase. Proc. Natl Acad. Sci. USA 98, 10996-11002.
4. von Bernhardi R., and, Ramirez G., (2001) Microglia-astrocyte interaction in Alzheimer's disease: friends or foes for the nervous system? Biol. Res. 34, 123-128.
5. Brawer J. R., Reichard G., Small L., and, Schipper H. M,. (1994) The origin and composition of peroxidase-positive granules in cysteamine-treated astrocytes in culture. Brain Res. 633, 9-20.
6. Calabrese V., Cornelius C., Mancuso C., Barone E., Calafato S., Bates T., Rizzarelli E., and, Kostova A. T., (2009) Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases. Front. Biosci. 14, 376-397.
7. Chopra V. S., Moozar K. L., Mehindate K., and, Schipper H. M,. (1997) A cellular stress model for the differential expression of glial lysosomal cathepsins in the aging nervous system. Exp. Neurol. 147, 221-228.
8. Cornelius C., Perrotta R., Graziano A., Calabrese E. J., and, Calabrese V,. (2013) Stress responses, vitagenes and hormesis as critical determinants in aging and longevity: mitochondria as a "chi". Immun. Aging 10, 15.
9. Cruz-Sanchez F. F., Girones X., Ortega A., Alameda F., and, Lafuente J. V., (2010) Oxidative stress in Alzheimer's disease hippocampus: a topographical study. J. Neurol. Sci. 299, 163-167.
10. Dennery P. A., (2000) Regulation and role of heme oxygenase in oxidative injury. Curr. Top. Cell. Regul. 36, 181-199.
11. Doré S., Takahashi M., Ferris C. D., Zakhary R., Hester L. D., Guastella D., and, Snyder S. H., (1999) Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc. Natl Acad. Sci. USA 96, 2445-2450.
12. Frankel D., Mehindate K., and, Schipper H. M., (2000) Role of heme oxygenase-1 in the regulation of manganese superoxide dismutase gene expression in oxidatively-challenged astroglia. J. Cell. Physiol. 185, 80-86.
13. Galbraith R., (1999) Heme oxygenase: who needs it? Proc. Soc. Exp. Biol. Med. 222, 299-305.
14. Giulian D., Haverkamp L. J., Li J., Karshin W. L., Yu J., Tom D., Li X., and, Kirkpatrick J. B,. (1995) Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem. Int. 27, 119-137.
15. Giulian D., Haverkamp L. J., Yu J. H., Karshin W., Tom D., Li J., Kirkpatrick J., Kuo L. M., and, Roher A. E,. (1996) Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J. Neurosci. 16, 6021-6037.
16. Gould T. J., and, Feiro O. R., (2005) Age-related deficits in the retention of memories for cued fear conditioning are reversed by galantamine treatment. Behav. Brain Res. 165, 160-171.
17. Gown A. M., and, Willingham M. C., (2002). Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3. J. Histochem. Cytochem. 50, 449-454.
18. Gupta A., Schipper H. M., Alaoui-Jamali M., Szarek W. A., Nakatsu K., and, Vlahakis J. Z., (2008) Preparation of heterocyclic heme-oxygenase inhibitors and use in the treatment of cancer and CNS diseases.PCT Int. Appl., WO 2008151437 A1 20081218.
19. Hamel E., Nicolakakis N., Aboulkassim T., Ongali B., and, Tong X. K., (2008) Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease. Exp. Physiol. 93, 116-120.
20. Hou Y., Bao X. Q., and, Liu G. T,. (2009) The role of vitagenes in aging and Alzheimer's disease and relevant advances of pharmacological study. Yao Xue Xue Bao 44, 825-832.
21. Janetzky B., Reichmann H., Youdim M. B., and, Reiderer P,. (1997) Iron and oxidative damage in neurodegenerative disease. in Mitochondria and Free Radicals in Neurodegenerative Diseases (, Beal M. F., Howell N., and, Bodis-Wollner I., eds), pp. 407-421. Wiley-Liss, New York.
22. Jankowsky J. L., Fadale D. J., Anderson J., et al,. (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet., 13, 159-170.
23. Kappas A., Drummond G. S., and, Galbraith R. A., (1993) Prolonged clinical use of a heme oxygenase inhibitor: hematological evidence for an inducible but reversible iron-deficiency state. Pediatrics 91, 537-539.
24. Kinobe R. T., Vlahakis J. Z., Vreman H. J., Stevenson D. K., Brien J. F., Szarek W. A., and, Nakatsu K,. (2006) Selectivity of imidazole-dioxolane compounds for in vitro inhibition of microsomal haemoxygenase isoforms. Br. J. Pharmacol. 147, 307-315.
25. Klausner R. D., Rouault T. A., and, Harford J. B., (1993) Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 72, 19-28.
26. Kotilinek L. A., Westerman M. A., Wang Q., et al,. (2008) Cyclooxygenase-2 inhibition improves amyloid-β-mediated suppression of memory and synaptic plasticity. Brain 131, 651-664.
27. Lacoste B., Tong X. K., Lahjouji K., Couture R., and, Hamel E., (2013) Cognitive and cerebrovascular improvements following kinin B1 receptor blockade in Alzheimer's disease mice. J. Neuroinflammatio 10, 57.
28. Lee C. Y., and, Landreth G. E., (2010) The role of microglia in amyloid clearance from the AD brain. J. Neural. Transm. 117, 949-960.
29. Li L., Cao D., Kim H., Lester R., and, Fukuchi K., (2006) Simvastatin enhances learning and memory independent of amyloid load in mice. Ann. Neurol. 60, 729-739.
30. Llesuy S. F., and, Tomaro M. L., (1994) Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochim. Biophys. Acta. 1223, 9-14.
31. Mawal Y., Berlin D., Kravitz S., and, Schipper H. M,. (2002) Heme oxygenase-1 and Alzheimer disease, in Heme oxygenase in Biology and Medicine (, Alam J., Abraham N. G., and, Nath K. A., eds), pp. 145-155. Kluwer Academic/Plenum Publishers, New York.
32. McCoubrey W. K. Jr, Huang T. J., and, Maines M. D., (1997) Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur. J. Biochem. 247, 725-732.
33. McGeer E. G., and, McGeer P. L., (2010) Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy. J. Alzheimers Dis. 19, 355-361.
34. McLaren J., Brawer J. R., and, Schipper H. M., (1992) Iron content correlates with peroxidase activity in cysteamine-induced astroglial organelles. J. Histochem. Cytochem. 40, 1887-1897.
35. Michelucci A., Heurtaux T., Grandbarbe L., Morga E., and, Heuschling P., (2009) Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-beta. J. Neuroimmunol. 210, 3-12.
36. Nakagami T., Toyomura K., Kinoshita T., and, Morisawa S,. (1993) A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochim. Biophys. Acta 1158, 189-193.
37. Nicolakakis N., Aboulkassim T., Ongali B., Lecrux C., Fernandes P., Rosa-Neto P., Tong X. K., and, Hamel E., (2008) Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist. J. Neuroscience 28, 9287-9296.
38. Park L., Zhou P., Pitstick R., et al,. (2008) Nox2-derived radicals contribute to neurovascular and behavioural dysfunction in mice overexpressing the amyloid precursor protein. Proc. Natl Acad. Sci. USA, 105, 1347-1352.
39. Pistell P. J., and, Ingram D. K., (2010) Development of a water-escape motivated version of the Stone T-maze for mice. Neuroscience 166, 61-72.
40. Richardson D. R., and, Ponka P., (1997) The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim. Biophys. Acta 1331, 1-40.
41. Roman G., Riley J. G., Vlahakis J. Z., Kinobe R. T., Brien J. F., Nakatsu K., and, Szarek W. A., (2007) Heme oxygenase inhibition by 2-oxy-substituted 1-(1H-imidazol-1- yl)-4-phenylbutanes: effect of halogen substitution in the phenyl ring. Bioorg. Med. Chem. 15, 3225-3234.
42. Ryter S. W., and, Tyrrell R. M., (2000) The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties. Free Radic. Biol. Med. 28, 289-309.
43. Scapagnini G., D'Agata V., Calabrese V., Pascale A., Colombrita C., Alkon D., and, Cavallaro S., (2002) Gene expression profiles of heme oxygenase isoforms in the rat brain. Brain Res. 954, 51-59.
44. Schipper H. M., (2000) Heme oxygenase-1: role in brain aging and neurodegeneration. Exp. Gerontol. 35, 821-830.
45. Schipper H. M., Scarborough D. E., Lechan R. M., and, Reichlin S,. (1990) Gomori-positive astrocytes in primary culture: effects of in vitro age and cysteamine exposure. Brain Res. Dev. Brain Res. 54, 71-79.
46. Schipper H. M., Vininsky R., Brull R., Small L., and, Brawer J. R,. (1998) Astrocyte mitochondria: a substrate for iron deposition in the aging rat substantia nigra. Exp. Neurol. 152, 188-196.
47. Schipper H. M., Bennett D. A., Liberman A., Bienias J. L., Schneider J. A., Kelly J., and, Arvanitakis Z,. (2006) Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol. Aging 27, 252-261.
48. Solito E., and, Sastre M., (2012) Microglia function in Alzheimer's disease. Front Pharmacol. 10, 14. doi: 10.3389/fphar.2012.00014.
49. Song W., Su H., Song S., Paudel H. K., and, Schipper H. M,. (2006) Over-expression of heme oxygenase-1 promotes oxidative mitochondrial damage in rat astroglia. J. Cell. Physiol. 206, 655-663.
50. Stocker R., Yamamoto Y., McDonagh A. F., Glazer A. N., and, Ames B. N,. (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235, 1043-1046.
51. Stranahan A. M., and, Mattson M. P., (2010) Selective vulnerability of neurons in layer II of the entorhinal cortex during aging and Alzheimer's disease. Neural Plast. 2010, 1-8.
52. Suttner D. M., and, Dennery P. A., (1999) Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron. FASEB J. 13, 1800-1809.
53. Tong X. K., Lecrux C., Rosa-Neto P., and, Hamel E., (2012) Age-dependent rescue by simvastatinof Alzheimer's disease cerebrovascular and memory deficits. J. Neurosci. 32, 4705-4715.
54. Tuppo E. E., and, Arias H. R., (2005) The role of inflammation in Alzheimer's disease. Int. J. Biochem. Cell Biol. 37, 289-305.
55. Varnum M. M., and, Ikezu T., (2012) The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain. Arch. Immunol. Ther. Exp. 60, 251-266.
56. Verma A., Hirsch D. J., Glatt C. E., Ronnett G. V., and, Snyder S. H,. (1993) Carbon monoxide: a putative neural messenger. Science 259, 381-384.
57. Vlahakis J. Z., Hum M., Rahman M. N., Jia Z., Nakatsu K., and, Szarek W. A., (2009) Synthesis and evaluation of imidazole-dioxolane compounds as selective heme oxygenase inhibitors: effect of substituents at the 4-position of the dioxolane ring. Bioorg. Med. Chem. 17, 2461-2475
58. Xing S., Shen D., Chen C., Wang J., and, Yu Z., (2014) Early induction of oxidative stress in a mouse model of Alzheimer's disease with heme oxygenase activity. Mol. Med. Rep. 10, 599-604.
59. Xu Y., Bismar T. A., Su J., et al,. (2010). Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion. J. Exp. Med. 207, 2421-2437.
60. Youdim M., (1994) Inorganic neurotoxins in neurodegenerative disorders without primary dementia. in Neurodegenerative Diseases (, Calne D. B., ed), pp. 251-276. W.B, Saunders, Philadelphia.
61. Zhang J., and, Piantadosi C. A., (1992) Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain. J. Clin. Invest. 90, 1193-1199.